Cell transplantation models / BIU-87

BIU-87 cell transplantation models

Bladder transitional cell carcinoma

Bladder TCC. s.c. locks Cell Physiol Biochem 3×10⁶ in RPMI-1640 SCID hind limb; ICLAC misidentification risk—STR required; bladder-wall ortho not locked.

SKU: MC-h314 · Disease models

Protocols(2)

BIU-87 subcutaneous xenograft

Human bladder TCC BIU-87 hind-limb s.c. CDX. This SOP uses Cell Physiol Biochem xenograft control arm: 3×10⁶ in RPMI-1640, SCID hind-limb s.c. (μL not stated). ICLAC lists misidentification risk—STR required; 2×10⁷ Matrigel recipe is another paper, not this page’s default. Do not copy 231’s 2×10⁶ / 100 μL.

Open full protocol →

BIU-87 bladder-wall orthotopic (parental dose not locked)

Parental BIU-87 bladder-wall orthotopic dose is not locked. Pilot required. Do not copy s.c. 3×10⁶.

Open full protocol →

Protocol index

Red [Non-metastatic] = local tumorigenesis, not a distant-met endpoint; [Weak metastasis evidence] = poorly supported for parental line—exploratory/negative-control use.

Related

Disclaimer: Research use only (RUO). Not clinical guidance or a substitute for institutional animal SOPs. In vivo work requires ethics approval. Inline [n] maps to each section’s reference list.